Finding the Cure

Tackle Kids Cancer raises funds to support crucial pediatric cancer research and innovative patient care programs occurring at the Children’s Cancer Institute at Hackensack University Medical Center. With over $5 million raised in the past two years, each dollar is bringing us closer to our mission – a world free of childhood cancer.

Your support for Tackle Kids Cancer helps make these current programs possible.

  • Implementation of CAR-T Cell Therapy.
  • Creation of a comprehensive neuro-oncology program, including the participation in 11 open studies with 2 others under development.
  • Establishment of a pain and palliative care program utilizing innovative technological intervention to help patients manage pain.
  • Development of an onco-fertility program to assist patients in preserving their fertility after treatment.
  • During the last 20 years, there have been only three cancer medications specifically developed for children.

    20% percent of pediatric cancers are still without a cure. Many of these patients are children with brain and spinal cord tumors, which carry an undue proportion of mortality and long-term side effects when compared to other cancers.

    2/3 of childhood cancer patients will have long-lasting chronic conditions from treatment

    Other programs funded through Tackle Kids Cancer include:

  • 2-Hydroxyoleic Acid Study to be launched in 2018. This new fatty acid drug has completed adult phase I testing in Europe with a positive response in advanced glioblastoma patients. When open, the trial will be open to patients with advanced brains and solid tumors, and will be a two-center study in cooperation with Dana-Farber Cancer Institute.
  • The Children’s Cancer Institute is New Jersey’s only pediatric bone marrow transplant center. The Transplant Clinical Trials Program focuses on improving cure rates as well as minimizing the short- and long-term side effects for children going through a bone marrow transplant.
  • Cure and Beyond Program is the most comprehensive survivorship program in New Jersey, and focuses on long-term health, emotional and social issues specific to pediatric cancer survivors.